{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:33:03Z","timestamp":1767151983487,"version":"build-2238731810"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A significant proportion of patients with non-alcoholic fatty liver disease (NAFLD) in Asian sub-continent are non-overweight and may have different underlying risk factors, lifestyles and metabolic profiles. Seven hundred fifty patients of NAFLD with raised alanine-amino-transferase (ALT) were divided into non-overweight and obese group based on their body mass index (BMI). Detailed dietary and lifestyle history were obtained through questionnaires and a detailed assessment of metabolic profile and liver stiffness was done. Normal BMI (&lt;\u200923\u00a0kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ) was found in 6.6% patients, of which 69.5% had raised ALT. Though the intake of dietary fat and exercise pattern were not different amongst these groups, yet the amount of aerated drinks was higher in obese subjects (12\u2009\u00b1\u200917 vs. 7\u2009\u00b1\u20097.5\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005). Serum low-density lipoprotein (111\u2009\u00b1\u200925.6 vs. 127.7\u2009\u00b1\u200932.7\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.04) and insulin resistance based on HOMA-IR\u2009&gt;\u20092 were significantly higher in obese group (4.1\u2009\u00b1\u20090.36 vs. 2.0\u2009\u00b1\u20090.15\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001). Insulin resistance and dyslipidemia were prevalent in 12% and 25% non-overweight patients respectively. Metabolic syndrome was more common in obese subjects. In addition, magnetic resonance elastography showed higher mean liver fat in the obese group with similar hepatic fibrosis. Non-overweight patients with NAFLD had lower insulin resistance and prevalence of dyslipidaemia at similar dietary and exercise pattern.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-72306-x","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T17:28:45Z","timestamp":1600363725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4497-9209","authenticated-orcid":false,"given":"Mithun","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-1675","authenticated-orcid":false,"given":"Anand","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1073-6295","authenticated-orcid":false,"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Bhaskar","family":"Nori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Jagtap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duvurr Nageshwar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padaki Nagaraja","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"6037","key":"72306_CR1","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","volume":"332","author":"JC Cohen","year":"2011","unstructured":"Cohen, J. C., Horton, J. D. & Hobbs, H. H. Human fatty liver disease: old questions and new insights. Science 332(6037), 1519\u20131523. https:\/\/doi.org\/10.1126\/science.1204265 (2011).","journal-title":"Science"},{"issue":"10","key":"72306_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1046\/j.1440-1746.2002.02846.x","volume":"17","author":"K Omagari","year":"2010","unstructured":"Omagari, K. et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J. Gastroenterol. Hepatol. 17(10), 1098\u20131105. https:\/\/doi.org\/10.1046\/j.1440-1746.2002.02846.x (2010).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"72306_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","volume":"50","author":"JG Fan","year":"2009","unstructured":"Fan, J. G. & Farell, G. C. Epidemiology of non alcoholic fatty liver disease in China. J. Hepatol. 50, 204\u2013210. https:\/\/doi.org\/10.1016\/j.jhep.2008.10.010 (2009).","journal-title":"J. Hepatol."},{"issue":"5","key":"72306_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/hep.23567","volume":"51","author":"K Das","year":"2010","unstructured":"Das, K. et al. Nonobese population in a developing country has a high prevalence of non-alcoholic fatty liver and significant liver disease. Hepatology 51(5), 1593\u20131602. https:\/\/doi.org\/10.1002\/hep.23567 (2010).","journal-title":"Hepatology"},{"key":"72306_CR5","doi-asserted-by":"publisher","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [published correction appears in Lancet 363(9412): 902]. Lancet. 363(9403): 157\u2013163. https:\/\/doi.org\/10.1016\/S0140-6736(03)15268-3. (2004).","DOI":"10.1016\/S0140-6736(03)15268-3"},{"issue":"2","key":"72306_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"S Bellentani","year":"2000","unstructured":"Bellentani, S. et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132(2), 112\u2013117. https:\/\/doi.org\/10.7326\/0003-4819-132-2-200001180-00004 (2000).","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"72306_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4103\/2230-8210.113758","volume":"17","author":"R Kumar","year":"2013","unstructured":"Kumar, R. et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease?. Indian J. Endocrinol. Metab. 17(4), 665\u2013671. https:\/\/doi.org\/10.4103\/2230-8210.113758 (2013).","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"1","key":"72306_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1), 328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367 (2018).","journal-title":"Hepatology"},{"issue":"1","key":"72306_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00330-013-2978-8","volume":"24","author":"SK Venkatesh","year":"2014","unstructured":"Venkatesh, S. K., Wang, G., Lim, S. G. & Wee, A. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur. Radiol. 24(1), 70\u201378. https:\/\/doi.org\/10.1007\/s00330-013-2978-8 (2014).","journal-title":"Eur. Radiol."},{"issue":"17","key":"72306_CR10","doi-asserted-by":"publisher","first-page":"7892","DOI":"10.1073\/pnas.1003585107","volume":"107","author":"Y Huang","year":"2010","unstructured":"Huang, Y. et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc. Natl. Acad. Sci. USA 107(17), 7892\u20137897. https:\/\/doi.org\/10.1073\/pnas.1003585107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"72306_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to non-alcoholic fatty liver disease. Nat. Genet. 40(12), 1461\u20131465. https:\/\/doi.org\/10.1038\/ng.257 (2008).","journal-title":"Nat. Genet."},{"issue":"11","key":"72306_CR12","doi-asserted-by":"publisher","first-page":"e50256","DOI":"10.1371\/journal.pone.0050256","volume":"7","author":"XE Peng","year":"2012","unstructured":"Peng, X. E. et al. Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population. PLoS ONE 7(11), e50256. https:\/\/doi.org\/10.1371\/journal.pone.0050256 (2012).","journal-title":"PLoS ONE"},{"key":"72306_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.7869\/tg.118","volume":"34","author":"SP Singh","year":"2013","unstructured":"Singh, S. P. et al. Profile of patients with incidentally detected non-alcoholic fatty liver disease (IDNAFLD) in coastal eastern India. Trop. Gastroenterol. 34, 144\u2013152. https:\/\/doi.org\/10.7869\/tg.118 (2013).","journal-title":"Trop. Gastroenterol."},{"key":"72306_CR14","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s10620-006-9136-y","volume":"52","author":"A Duseja","year":"2007","unstructured":"Duseja, A. et al. The clinicopathological profile of Indian patients with non alcoholic fatty liver disease (NAFLD) is different from that in the West. Dig. Dis. Sci. 52, 2368\u20132374. https:\/\/doi.org\/10.1007\/s10620-006-9136-y (2007).","journal-title":"Dig. Dis. Sci."},{"key":"72306_CR15","first-page":"285","volume":"129","author":"S Bajaj","year":"2009","unstructured":"Bajaj, S. et al. A case\u2013control study on insulin resistance, metabolic co variates and prediction score in non-alcoholic fatty liver disease. Indian J. Med. Res. 129, 285\u2013292 (2009).","journal-title":"Indian J. Med. Res."},{"key":"72306_CR16","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.3748\/wjg.v12.i21.3400","volume":"12","author":"K Madan","year":"2006","unstructured":"Madan, K. et al. Non-alcoholic fatty liver disease may not be a severe disease. at presentation among Asian Indians. World J. Gastroenterol. 12, 3400\u20133405. https:\/\/doi.org\/10.3748\/wjg.v12.i21.3400 (2006).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"72306_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14218\/JCTH.2016.00045","volume":"5","author":"S Singh","year":"2007","unstructured":"Singh, S., Kuftinec, G. N. & Sarkar, S. Non-alcoholic fatty liver disease in South Asians: a review of the literature. J. Clin. Transl. Hepatol. 5(1), 76\u201381. https:\/\/doi.org\/10.14218\/JCTH.2016.00045 (2007).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"72306_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/aje\/kws448","volume":"178","author":"M Lazo","year":"2013","unstructured":"Lazo, M. et al. Prevalence of non-alcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994. Am. J. Epidemiol. 178, 38\u201345. https:\/\/doi.org\/10.1093\/aje\/kws448 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"72306_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams, C. D. et al. Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124\u2013131. https:\/\/doi.org\/10.1053\/j.gastro.2010.09.038 (2011).","journal-title":"Gastroenterology"},{"issue":"6","key":"72306_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64(6), 1388\u20131402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004 (2016).","journal-title":"J. Hepatol."},{"key":"72306_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.gastro.2008.03.076","volume":"135","author":"L Huwart","year":"2008","unstructured":"Huwart, L. et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135, 32\u201340. https:\/\/doi.org\/10.1053\/j.gastro.2008.03.076 (2008).","journal-title":"Gastroenterology"},{"issue":"5","key":"72306_CR22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/jmri.21523","volume":"28","author":"SF Bensamoun","year":"2008","unstructured":"Bensamoun, S. F. et al. Measurement of liver stiffness with two imaging techniques: magnetic resonance elastography and ultrasound elastometry. J. Magn. Reson. Imaging 28(5), 1287\u20131292. https:\/\/doi.org\/10.1002\/jmri.21523 (2008).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"12","key":"72306_CR23","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/j.1365-2036.2011.04668.x","volume":"33","author":"S Petta","year":"2011","unstructured":"Petta, S. et al. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol. Ther. 33(12), 1350\u20131360. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04668.x (2011).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"9","key":"72306_CR24","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/ajg.2015.235","volume":"110","author":"JL Wei","year":"2015","unstructured":"Wei, J. L. et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance Spectroscopy. Am. J. Gastroenterol. 110(9), 1306\u20131315. https:\/\/doi.org\/10.1038\/ajg.2015.235 (2015).","journal-title":"Am. J. Gastroenterol."},{"issue":"29","key":"72306_CR25","doi-asserted-by":"publisher","first-page":"10128","DOI":"10.3748\/wjg.v20.i29.10128","volume":"20","author":"L Montesi","year":"2014","unstructured":"Montesi, L. et al. Physical activity support or weight loss counselling for non-alcoholic fatty liver disease?. World J. Gastroenterol. 20(29), 10128\u201310136. https:\/\/doi.org\/10.3748\/wjg.v20.i29.10128 (2014).","journal-title":"World J. Gastroenterol."},{"key":"72306_CR26","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s11695-016-2123-2","volume":"26","author":"M Luger","year":"2016","unstructured":"Luger, M. et al. Prevalence of liver fibrosis and its association with non-invasive fibrosis and metabolic markers in morbidly obese patients with vitamin D deficiency. Obes. Surg. 26, 2425\u20132432. https:\/\/doi.org\/10.1007\/s11695-016-2123-2 (2016).","journal-title":"Obes. Surg."},{"issue":"1","key":"72306_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3164\/jcbn.15-54","volume":"58","author":"Y Dai","year":"2016","unstructured":"Dai, Y., Zhu, J., Meng, D., Yu, C. & Li, Y. Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis. J. Clin. Biochem. Nutr. 58(1), 76\u201383. https:\/\/doi.org\/10.3164\/jcbn.15-54 (2016).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"72306_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1758-5996-4-34","volume":"4","author":"K Hosoyamada","year":"2011","unstructured":"Hosoyamada, K. et al. Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol. Diabetol. Metab. Syndr. 4, 34. https:\/\/doi.org\/10.1186\/1758-5996-4-34 (2011).","journal-title":"Diabetol. Metab. Syndr."},{"issue":"1","key":"72306_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7869\/tg.2012.86","volume":"34","author":"G Bhat","year":"2013","unstructured":"Bhat, G., Baba, C. S., Pandey, A., Kumari, N. & Choudhuri, G. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease. Trop. Gastroenterol. 34(1), 18\u201324. https:\/\/doi.org\/10.7869\/tg.2012.86 (2013).","journal-title":"Trop. Gastroenterol."},{"issue":"6","key":"72306_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.dld.2017.02.003","volume":"49","author":"V Jaruvongvanich","year":"2017","unstructured":"Jaruvongvanich, V., Ahuja, W., Sanguankeo, A., Wijarnpreecha, K. & Upala, S. Vitamin D and histologic severity of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Dig. Liver Dis. 49(6), 618\u2013622. https:\/\/doi.org\/10.1016\/j.dld.2017.02.003 (2017).","journal-title":"Dig. Liver Dis."},{"key":"72306_CR31","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/ajg.2016.406","volume":"111","author":"YA Patel","year":"2016","unstructured":"Patel, Y. A. et al. Vitamin D is not associated with severity in NAFLD: results of a paired clinical and gene expression profile analysis. J. Korean Med. Sci. 111, 1591\u20131598. https:\/\/doi.org\/10.1038\/ajg.2016.406 (2016).","journal-title":"J. Korean Med. Sci."},{"key":"72306_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2020.02.026","volume":"299","author":"K Konishi","year":"2020","unstructured":"Konishi, K. et al. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. Atherosclerosis 299, 32\u201337. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.02.026 (2020).","journal-title":"Atherosclerosis"},{"key":"72306_CR33","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to non-alcoholic fatty liver disease. Nat. Genet. 40, 1461\u20131465. https:\/\/doi.org\/10.1038\/ng.257 (2008).","journal-title":"Nat. Genet."},{"issue":"5","key":"72306_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jceh.2019.02.001","volume":"9","author":"G Bale","year":"2019","unstructured":"Bale, G. et al. Whole-exome sequencing identifies a variant in phosphatidylethanolamine N-methyltransferase gene to be associated with lean-nonalcoholic fatty liver disease. J. Clin. Exp. Hepatol. 9(5), 561\u2013568. https:\/\/doi.org\/10.1016\/j.jceh.2019.02.001 (2019).","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"26","key":"72306_CR35","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.4254\/wjh.v9.i26.1101","volume":"9","author":"G Bale","year":"2017","unstructured":"Bale, G. et al. Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities. World J. Hepatol. 9(26), 1101\u20131107. https:\/\/doi.org\/10.4254\/wjh.v9.i26.1101 (2017).","journal-title":"World J. Hepatol."},{"key":"72306_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature0882","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59\u201365. https:\/\/doi.org\/10.1038\/nature0882 (2010).","journal-title":"Nature"},{"issue":"4","key":"72306_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/nu10040440","volume":"10","author":"M Mahamid","year":"2018","unstructured":"Mahamid, M. et al. Folate and B12 levels correlate with histological severity in NASH patients. Nutrients 10(4), 440. https:\/\/doi.org\/10.3390\/nu10040440 (2018).","journal-title":"Nutrients"},{"issue":"2","key":"72306_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jceh.2015.02.002","volume":"5","author":"M Sharma","year":"2015","unstructured":"Sharma, M. et al. The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. J. Clin. Exp. Hepatol. 5(2), 147\u2013158. https:\/\/doi.org\/10.1016\/j.jceh.2015.02.002 (2015).","journal-title":"J. Clin. Exp. Hepatol."}],"updated-by":[{"DOI":"10.1038\/s41598-021-87449-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72306-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72306-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72306-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:43:18Z","timestamp":1670337798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72306-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72306"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72306-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"28 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-87449-8","URL":"https:\/\/doi.org\/10.1038\/s41598-021-87449-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15232"}}